Journal list menu
Export Citations
Download PDFs
Perspectives
Free Access
free
The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed?
- Pages: 441-451
- First Published: 06 October 2010
Free Access
free
Evidence-based policy on dietary calcium and vitamin D†
- Pages: 452-454
- First Published: 04 January 2011
Free Access
free
Why the IOM recommendations for vitamin D are deficient†
- Pages: 455-457
- First Published: 04 January 2011
Commentary
Original Articles
Free Access
free
Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: Derivation and validation of a hybrid system†
- Pages: 460-467
- First Published: 13 September 2010
Free Access
free
Active shape modeling of the hip in the prediction of incident hip fracture
- Pages: 468-474
- First Published: 27 September 2010
Free Access
free
Abnormal bone remodeling in patients with spontaneous painful vertebral fracture†
- Pages: 475-485
- First Published: 02 September 2010
Free Access
free
Long-term cadmium exposure and the association with bone mineral density and fractures in a population-based study among women
- Pages: 486-495
- First Published: 23 August 2010
Free Access
free
BMI and fracture risk in older men: The osteoporotic fractures in men study (MrOS)
- Pages: 496-502
- First Published: 02 September 2010
Free Access
free
Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis
- Pages: 503-511
- First Published: 02 September 2010
Free Access
free
Comparison of intravenous and intramuscular neridronate regimens for the treatment of paget disease of bone
- Pages: 512-518
- First Published: 02 September 2010
Free Access
free
Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis†
- Pages: 519-529
- First Published: 13 September 2010
Free Access
free
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis†
- Pages: 530-537
- First Published: 13 September 2010
Free Access
free
The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: Results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial
- Pages: 538-545
- First Published: 01 October 2010
Free Access
free
Influence of long-term postmenopausal hormone-replacement therapy on estimated structural bone strength: A study in discordant monozygotic twins
- Pages: 546-552
- First Published: 27 September 2010
Free Access
free
Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996–2007
- Pages: 553-560
- First Published: 02 September 2010
Free Access
free
Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures
- Pages: 561-568
- First Published: 27 September 2010
Free Access
free
Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents
- Pages: 569-581
- First Published: 13 September 2010
Free Access
free
Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation
- Pages: 582-590
- First Published: 03 September 2010
Free Access
free
Double disruption of α2A- and α2C -adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype
- Pages: 591-603
- First Published: 02 September 2010
Free Access
free
An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation
- Pages: 604-617
- First Published: 23 August 2010
Free Access
free
Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone
- Pages: 618-629
- First Published: 02 September 2010
Free Access
free
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo
- Pages: 630-643
- First Published: 03 September 2010
Free Access
free
Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways
- Pages: 644-656
- First Published: 02 September 2010
Free Access
free
Calpain-6, a target molecule of glucocorticoids, regulates osteoclastic bone resorption via cytoskeletal organization and microtubule acetylation
- Pages: 657-665
- First Published: 02 September 2010
Clinical Vignette
Free Access
free
Mutations in FKBP10 cause recessive osteogenesis imperfecta and bruck syndrome
- Pages: 666-672
- First Published: 13 September 2010
Letter to the Editor
Free Access
free
Fat mass is a positive predictor of bone mass in adolescents
- Page: 673
- First Published: 04 January 2011
Reply
Free Access
free
Response to “fat mass is a positive predictor of bone mass in adolescents”
- Pages: 674-675
- First Published: 04 January 2011